122 related articles for article (PubMed ID: 22764400)
1. Blood pressure drugs compared. ACE inhibitors beat ARBs hands-down for survival benefit.
Harv Heart Lett; 2012 Jun; 22(10):5. PubMed ID: 22764400
[No Abstract] [Full Text] [Related]
2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
3. Is the jury out? Class specific differences on coronary outcomes with ACE-inhibitors and ARBs: insight from meta-analysis and The Blood Pressure Lowering Treatment Trialists' Collaboration.
Strauss MH; Lonn EM; Verma S
Eur Heart J; 2005 Nov; 26(22):2351-3. PubMed ID: 16219656
[No Abstract] [Full Text] [Related]
4. ACE inhibitors and ARBs: antihypertensive medications in CKD.
Szromba C
Nephrol Nurs J; 2005; 32(3):332-3. PubMed ID: 16035474
[No Abstract] [Full Text] [Related]
5. More is less? Optimal combination therapy for adequate blood pressure lowering in hypertension.
Kjeldsen SE; Hedner T; Narkiewicz K; Oparil S
Blood Press; 2008; 17(3):132-3. PubMed ID: 18665471
[No Abstract] [Full Text] [Related]
6. AT1-receptor blockers and ACE inhibitors: alternatives or partners?
Ruilope LM
Int J Clin Pract Suppl; 2000 Aug; (111):20-4. PubMed ID: 15977403
[No Abstract] [Full Text] [Related]
7. Renin inhibition--benefit beyond hypertension control.
Kher V
J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
9. [Renoprotective effects of ACE inhibitors and AT1 antagonists on diabetic nephropathy beyond blood pressure control].
Shionoiri H; Yasuda G; Takizawa T; Shionoiri F
Nihon Rinsho; 2005 Jun; 63 Suppl 6():394-9. PubMed ID: 15999741
[No Abstract] [Full Text] [Related]
10. Recent changes in the landscape of combination RAS blockade.
Epstein BJ; Smith SM; Choksi R
Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
Grothusen A; Divchev D; Luchtefeld M; Schieffer B
Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
[TBL] [Abstract][Full Text] [Related]
12. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Julius S
Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure control in kidney transplantation: therapeutic implications.
Premasathian NC; Muehrer R; Brazy PC; Pirsch JD; Becker BN
J Hum Hypertens; 2004 Dec; 18(12):871-7. PubMed ID: 15318162
[TBL] [Abstract][Full Text] [Related]
14. [Blood pressure control in Europe is worse than in the USA].
Minutolo R
G Ital Nefrol; 2007; 24(4):284. PubMed ID: 17659496
[No Abstract] [Full Text] [Related]
15. Benefits and risks of combination therapy in hypertension.
Node K
Hypertens Res; 2009 Sep; 32(9):727-8. PubMed ID: 19609269
[No Abstract] [Full Text] [Related]
16. [Effects of angiotensin-converting enzyme inhibitors in hypertension].
Rahn KH
Z Kardiol; 1988; 77 Suppl 3():69-71. PubMed ID: 2850690
[TBL] [Abstract][Full Text] [Related]
17. ARBs and ACEis together in the treatment of hypertension and its complications? current practical recommendations.
Ruilope LM; Segura J
Expert Opin Pharmacother; 2010 Nov; 11(16):2619-23. PubMed ID: 20977398
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients.
Hillebrand U; Suwelack BM; Loley K; Lang D; Reuter S; Amler S; Pavenstädt H; Hausberg M; Büssemaker E
Transpl Int; 2009 Nov; 22(11):1073-80. PubMed ID: 19624495
[TBL] [Abstract][Full Text] [Related]
19. Anti-diabetic effect of blockade of the renin-angiotensin system.
Ando K; Fujita T
Diabetes Obes Metab; 2006 Jul; 8(4):396-403. PubMed ID: 16776746
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive drugs and fibrinolytic function.
Fogari R; Zoppi A
Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
